These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 119047

  • 1. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim-nitrofuratoin combination.
    Patil P, Sharma V, Joshi BN.
    J Postgrad Med; 1979 Jul; 25(3):162-5. PubMed ID: 119047
    [No Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
    Anklesaria P, Paranjpe S, Gupta K, Acharya V, Paul T, Sheth UK.
    J Postgrad Med; 1976 Oct; 22(4):171-5. PubMed ID: 802242
    [No Abstract] [Full Text] [Related]

  • 3. [Studies with nitrofurantoin: bacteriological studies with microorganisms causing urinary tract infections].
    Hein H.
    Arzneimittelforschung; 1969 Sep; 19(9):1579-84. PubMed ID: 4981210
    [No Abstract] [Full Text] [Related]

  • 4. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, Van Asbeck E, Roskott AM, Froeling F, Rozenberg-Arska M, Hoepelman IM.
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [Abstract] [Full Text] [Related]

  • 5. [Research on the frequency and sensitivity of microbial species isolated from urine to some antibiotics and chemotherapeutics].
    Pitzus E.
    Ig Mod; 1970 May; 63(7):400-19. PubMed ID: 4996878
    [No Abstract] [Full Text] [Related]

  • 6. [Resistance testing of the pathogens in urinary tract infections on agar dip-slides].
    Büsser E, Binswanger U.
    Schweiz Med Wochenschr; 1973 Sep 15; 103(37):1294-7. PubMed ID: 4201354
    [No Abstract] [Full Text] [Related]

  • 7. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
    Gismondo MR, Romeo MA, Lo Bue AM, Chisari G, Nicoletti G.
    Chemioterapia; 1986 Aug 15; 5(4):278-82. PubMed ID: 3094965
    [Abstract] [Full Text] [Related]

  • 8. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report].
    Schmid W.
    Med Welt; 1980 Jan 04; 31(1):32-6. PubMed ID: 6770223
    [No Abstract] [Full Text] [Related]

  • 9. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 10. In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
    Hunter IJ.
    Med J Aust; 1970 Aug 15; 2(7):317-21. PubMed ID: 4319442
    [No Abstract] [Full Text] [Related]

  • 11. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K, Korner B.
    Chemotherapy; 1974 Aug 15; 20(2):97-101. PubMed ID: 4210895
    [No Abstract] [Full Text] [Related]

  • 12. The action of trimethoprim-sulphamethoxazole against urinary pathogens.
    Smith DD, Bell SM, Levey JM, Loy YT.
    Med J Aust; 1972 Feb 05; 1(6):263-5. PubMed ID: 4552261
    [No Abstract] [Full Text] [Related]

  • 13. In vitro susceptibilities of canine urinary bacteria to selected antimicrobial agents.
    Rohrich PJ, Ling GV, Ruby AL, Jang SS, Johnson DL.
    J Am Vet Med Assoc; 1983 Oct 15; 183(8):863-7. PubMed ID: 6415021
    [Abstract] [Full Text] [Related]

  • 14. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G, Wiedmer E.
    Schweiz Med Wochenschr; 1971 Sep 25; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract] [Full Text] [Related]

  • 15. [Varying sensitivity of Gram-negative bacteria in the urine to nitrofurantoin itself, to combined nitrofurantoin-sulphadiazine and combined sulphonamide-trimethoprim (author's transl)].
    Sixl-Voigt B, Brunner E.
    Wien Klin Wochenschr; 1979 Mar 30; 91(7):218-21. PubMed ID: 433283
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Etiology and susceptibility of urinary tract isolates in Kosova.
    Raka L, Mulliqi-Osmani G, Berisha L, Begolli L, Omeragiq S, Parsons L, Salfinger M, Jaka A, Kurti A, Jakupi X.
    Int J Antimicrob Agents; 2004 Mar 30; 23 Suppl 1():S2-5. PubMed ID: 15037322
    [Abstract] [Full Text] [Related]

  • 18. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A.
    Int J Infect Dis; 2009 Mar 30; 13(2):140-4. PubMed ID: 18703368
    [Abstract] [Full Text] [Related]

  • 19. The use of trimethoprim-sulphamethoxazole in the treatment of complicated urinary tract infection.
    Sillar S.
    Aust N Z J Surg; 1972 May 30; 41(4):368-71. PubMed ID: 4623553
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.